Results 281 to 290 of about 283,899 (330)

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation. [PDF]

open access: yesJ Inflamm (Lond)
Seillier C   +7 more
europepmc   +1 more source

An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 12, Page 2713-2729, June 2025.
Background and Purpose Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by fibroblast activation and abnormal accumulation of extracellular matrix in the lungs. We previously demonstrated the importance of the heat shock protein αB‐crystallin (HSPB5) in TGF‐β1 profibrotic signalling, which suggests that HSPB5 could be a new ...
Pierre‐Marie Boutanquoi   +17 more
wiley   +1 more source

Obesity‐related glomerulopathy: How it happens and future perspectives

open access: yesDiabetic Medicine, Volume 42, Issue 6, June 2025.
Abstract Obesity‐related glomerulopathy (ORG) is an emerging complication of excess adiposity. Its incidence rises alongside the obesity pandemic. Up to 40% of individuals can be affected by ORG, irrespective of the status of glomerular filtration rate and albuminuria.
Jian‐Wen Samuel Lee‐Boey   +7 more
wiley   +1 more source

-315-CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (TPA) IN EXPERIMENTAL MODEL

open access: bronze, 1986
Katsuo Kanmatsuse   +7 more
openalex   +2 more sources

Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue S3, Page 31-47, June 2025.
Abstract Metformin, a synthetic biguanide, is widely used to manage type 2 diabetes, and is commonly prescribed in polycystic ovary syndrome (PCOS) to address insulin resistance and associated metabolic and reproductive disturbances. PCOS is characterised by hormonal imbalances such as hyperandrogenism and anovulation, metabolic abnormalities including
Saeede Saadati   +5 more
wiley   +1 more source

Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration. [PDF]

open access: yesJ Clin Med
Ando M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy